Weight Loss

Body composition through the menopause transition

Menopause changes where fat is stored and how much lean tissue you carry, even when body weight changes little. As estrogen declines, fat storage tends to shift from the hips and thighs toward the abdomen. Abdominal fat has a closer association with insulin resistance and cardiovascular risk than lower-body fat.

The longitudinal Study of Women's Health Across the Nation analysis found that fat gain accelerated and lean mass declined during the menopause transition. The underlying pace of weight gain did not change at menopause, which helps explain why the scale can miss the tissue shift.

Age-related muscle loss begins before menopause. The transition adds a faster period of lean-tissue loss for many women. Less muscle lowers resting energy expenditure, so the meals and activity pattern that maintained your weight earlier in adulthood may produce a different result later.

Your physician can compare weight, waist change, body-composition data, and menopause stage rather than use body weight alone. Build the goal around reducing abdominal fat, preserving lean tissue, and tracking change over time.

Thyroid, insulin and the markers that stall progress

Thyroid dysfunction, reduced insulin sensitivity, and polycystic ovary syndrome create separate barriers to fat loss that require different testing. The American Thyroid Association reports that women are five to eight times more likely than men to develop thyroid problems. Hypothyroidism slows metabolic rate and often brings fatigue, cold intolerance, or constipation.

Thyroid testing starts with thyroid-stimulating hormone, or TSH. Your physician interprets TSH alongside free T4, symptoms, and medications that affect thyroid testing.

Insulin sensitivity often declines through the menopause transition even when body weight remains stable. Fasting glucose shows current glucose regulation, while HbA1c reflects longer-term average blood glucose. Your physician uses fasting insulin with glucose results to assess insulin resistance.

For younger women, PCOS belongs in the assessment. The World Health Organization estimates that PCOS affects 8% to 13% of reproductive-age women and that up to 70% remain undiagnosed. PCOS assessment combines menstrual history with clinical or laboratory evidence of androgen excess and ovarian findings. Your physician also excludes thyroid disease and other causes.

At Opt Health, we examine insulin, leptin, ghrelin, cortisol, sex hormones, and thyroid function during a weight evaluation. Your physician uses the combined pattern to select thyroid treatment, metabolic care, PCOS management, or repeat testing.

Protecting bone and muscle while losing fat

During and after menopause, a safer fat-loss plan preserves muscle and loads bone regularly. Estrogen loss speeds bone turnover, which increases bone-density loss across menopause. The National Institute of Arthritis and Musculoskeletal and Skin Diseases identifies menopause-related estrogen loss as a major contributor to osteoporosis.

Aggressive weight loss without resistance training increases the chance that lost weight includes lean tissue. Resistance training stimulates muscle protein synthesis and gives bone a mechanical loading signal. Protein supplies the amino acids needed to repair and retain muscle. Weight-bearing activities such as brisk walking and stair climbing expose the skeleton to forces that help maintain bone strength.

The scale may show progress while muscle and bone are declining, so your physician needs more context than body weight. Our weight program may include a personalized diet plan developed by our nutritionists, habit and emotional-eating support, and an exercise program.

Chronic kidney disease changes an appropriate protein target, so your physician reviews it before the nutrition plan is set. A history of fragility fracture, diagnosed osteoporosis, joint disease, or balance problems changes exercise selection. Your physician or physical therapist can select lower-impact resistance and weight-bearing movements when those conditions are present. Choose a plan that pairs fat loss with adequate protein, progressive resistance, and exercise matched to your bone health.

The Opt Take on weight through the transition

We use repeated labs and physician review to build a weight plan for perimenopause, menopause, and post-menopause. Your first panel covers 55+ biomarkers across hormones, inflammation, cardiovascular risk, and other systems. Your Opt Health physician reviews the results with you in a 1:1 consultation and sets the treatment plan.

Foundation includes follow-up labs and a physician consultation twice a year. Optimization includes follow-up labs and a physician consultation four times a year. At each follow-up, your physician compares the new results with the prior panel and adjusts the plan. Membership is required for treatment, so Opt Health does not fit a one-time lab or standalone prescription. Choose Opt Health when you want an ongoing physician-led plan measured over time.

Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.